Chem. Biodiversity 2021, 18, e2100066
logical evaluation of certain sulfonamide containing heter-
ocyclic motifs’, Pol. Annals Med. 2014, 21, 75–81. DOI:
10.1016/j.poamed.2014.07.006.
‘Synthesis and antimicrobial activity of 6-triazolo-6-deoxy
eugenol glucosides’, Carbohydr. Res. 2015, 410, 1–8. DOI:
10.1016/j.carres.2015.04.002.
[14] G. Chen, H. Ren, A. Turpoff, A. Arefolov, R. Wilde, J.
Takasugi, A. Khan, N. Almstead, Z. Gu, T. Komatsu, C.
Freund, J. Breslin, J. Colacino, J. Hedrick, M. Weetall, G. M.
Karp, ‘Discovery of N-(4’-(indol-2-yl)phenyl)sulfonamides as
novel inhibitors of HCV replication’, Bioorg. Med. Chem.
[25] T. B. De Souza, K. M. O. Brito, N. C. Silva, R. P. Rocha, G. F.
Sousa, L. P. Duarte, L. F. L. Coelho, A. L. T. Dias, M. P. Veloso,
D. T. Carvalho, D. F. Dias, ‘New eugenol glucoside-based
derivative shows fungistatic and fungicidal activity against
opportunistic Candida glabrata’, Chem. Biol. Drug Des.
2016, 87, 83–90. DOI: 10.1111/cbdd.12625.
Lett.
2013,
23,
3942–3946.
DOI:
10.1016/
j.bmcl.2013.04.050.
[26] P. H. O. Abrão, R. B. Pizi, T. B. De Souza, N. C. Silva, A. M.
Fregnan, F. N. Silva, L. F. L. Coelho, L. C. C. Malaquias,
A. L. T. Dias, D. F. Dias, M. P. Veloso, D. T. Carvalho, ‘Syn-
thesis and biological evaluation of new eugenol Mannich
bases as promising antifungal agents’, Chem. Biol. Drug
Des. 2015, 86, 459–465. DOI: 10.1111/cbdd.12504.
[27] T. M. M. Hipólito, G. T. L. Bastos, T. W. L. Barbosa, T. B.
De Souza, L. F. L. Coelho, A. L. T. Dias, I. C. Rodríguez, M. H.
Dos Santos, D. F. Dias, L. L. Franco, D. T. Carvalho, ‘Syn-
thesis, Activity, and Docking Studies of Eugenol-Based
Glucosides as New Agents against Candida sp.’, Chem. Biol.
Drug Des. 2018, 92, 1514–1524. DOI: 10.1111/cbdd.13318.
[28] T. Dos Santos, C. M. Coelho, T. C. Elias, F. S. Siqueira,
E. S. S. D. Nora, M. M. A. De Campos, G. A. P. de Souza,
L. F. L. Coelho, D. T. Carvalho, ‘Synthesis and biological
evaluation of new eugenol-derived 1,2,3-triazoles as anti-
mycobacterial agents’, J. Braz. Chem. Soc. 2019, 30, 1425–
1436. DOI: 10.21577/0103-5053.20190038.
[15] C. R. Andrighetti-Fröhner, K. N. de Oliveira, D. Gaspar-Silva,
L. K. Pacheco, A. C. Joussef, M. Steindel, C. M. O. Simões,
A. M. T. de Souza, U. O. Magalhaes, I. F. Afonso, C. R.
Rodrigues, R. J. Nunes, H. C. Castro, ‘Synthesis, biological
evaluation and SAR of sulfonamide 4-methoxychalcone
derivatives with potential antileishmanial activity’, Eur. J.
Med. Chem. 2009, 44, 755–763. DOI: 10.1016/j.ej-
mech.2008.04.016.
[16] J. Lal, S. K. Gupta, D. Thavaselvam, D. D. Agarwal, ‘Biological
activity, design, synthesis and structure-activity relation-
ship of some novel derivatives of curcumin containing
sulfonamides’, Eur. J. Med. Chem. 2013, 64, 579–588. DOI:
10.1016/j.ejmech.2013.03.012.
[17] S. Hemaiswarya, M. Doble, ‘Synergistic interaction of
eugenol with antibiotics against Gram negative bacteria’,
Phytomedicine 2009, 16, 997–1005. DOI: 10.1016/
j.phymed.2009.04.006.
[18] D. Campaniello, M. R. Corbo, M. Sinigaglia, ‘Antifungal
Activity of Eugenol against Penicillium, Aspergillus, and
Fusarium Species’, J. Food Prot. 2010, 73, 1124–1128. DOI:
10.4315/0362-028X-73.6.1124.
[19] J. Qiu, H. Feng, J. Lu, H. Xiang, D. Wang, J. Dong, J. Wang,
X. Wang, J. Liu, X. Deng, ‘Eugenol reduces the expression
of virulence-related exoproteins in Staphylococcus aureus’,
Appl. Environ. Microbiol. 2010, 76, 5846–5851. DOI:
10.1128/AEM.00704-10.
[20] H. Carrasco, M. Raimondi, L. Svetaz, M. di Liberto, M. V.
Rodriguez, L. Espinoza, A. Madrid, S. Zacchino, ‘Antifungal
activity of eugenol analogs. Influence of different substitu-
ents and studies on mechanism of action’, Molecules 2012,
17, 1002–1024. DOI: 10.3390/molecules17011002.
[21] B. Das, D. Mandal, S. K. Dash, S. Chattopadhyay, S. Tripathy,
D. P. Dolai, S. K. Dey, S. Roy, ‘Eugenol Provokes ROS-
Mediated Membrane Damage-Associated Antibacterial
Activity against Clinically Isolated Multidrug-Resistant
Staphylococcus aureus Strains’, Infect. Dis.: Res. Treat. 2016,
9, 11–19. DOI: 10.4137/idrt.s31741.
[29] D. J. Alvarenga, L. M. F. Matias, L. M. Oliveira, L. P. M. O.
Leão, J. A. Hawkes, B. V. B. Raimundo, L. F. D. Castro,
M. M. A. De Campos, F. S. Siqueira, T. Dos Santos, D. T.
Carvalho, ‘Exploring how structural changes to new Licarin
A derivatives effects their bioactive properties against
rapid growing mycobacteria and biofilm formation’, Mi-
crob. Pathog. 2020, 144, 104203. DOI: 10.1016/j.mic-
path.2020.104203.
[30] H. Azevedo-Barbosa, G. Á. Ferreira-Silva, C. F. Silva, T. B.
de Souza, D. F. Dias, A. C. C. de Paula, M. Ionta, D. T.
Carvalho, ‘Phenylpropanoid-based sulfonamide promotes
cyclin D1 and cyclin E down-regulation and induces cell
cycle arrest at G1/S transition in estrogen positive MCF-
7 cell lines’, Toxicol. in Vitro 2019, 59, 150–160. DOI:
10.1016/j.tiv.2019.04.023.
[31] Clinical and Laboratory Standards Institute (CLSI) Database,
‘Susceptibility Testing of Mycobacteria, Nocardia spp. and
Other Aerobic Actinomycetes’, 3rd Edition: M24-A2. 2011.
biology/documents/m24/. Accessed 02/10/2020.
[22] A. Marchese, R. Barbieri, E. Coppo, I.E. Orhan, S. F. Nabavi,
M. Izadi, M. Abdollahi, M. Nabavi, M. Ajami, ‘Critical Reviews
in Microbiology Antimicrobial activity of eugenol and
essential oils containing eugenol: A mechanistic view-
point’, Crit. Rev. Microbiol. 2017, 43, 668–689. DOI:
10.1080/1040841X.2017.1295225.
[23] T. B. De Souza, M. Orlandi, L. F. L. Coelho, L. C. C. Malaquias,
A. L. T. Dias, R. R. Carvalho, N. C. Silva, D. T. Carvalho,
‘Synthesis and in vitro evaluation of antifungal and
cytotoxic activities of eugenol glycosides’, Med. Chem. Res.
2014, 23, 496–502. DOI: 10.1007/s00044-013-0669-2.
[24] T. B. De Souza, P. O. B. Raimundo, S. F. Andrade, T. M. M.
Hipólito, N. C. Silva, A. L. T. Dias, M. Ikegaki, R. P. Rocha,
L. F. L. Coelho, M. P. Veloso, D. T. Carvalho, D. F. Dias,
[32] Clinical and Laboratory Standards Institute (CLSI) Database,
‘Performance Standards for antimicrobial susceptibility
standards/products/microbiology/documents/m100/. Ac-
cessed 02/10/2020.
[33] M. J. García-Galán, M. S. Díaz-Cruz, D. Barceló, ‘Identifica-
tion and determination of metabolites and degradation
products of sulfonamide antibiotics’, TrAC Trends Anal.
Chem.
2008,
27,
1008–1022.
DOI:
10.1016/
j.trac.2008.10.001.
[34] ‘Manual Nacional de Vigilância Laboratorial da Tuberculose
e Outras Micobactérias’, 2008. Ministério da Saúde, Brasília,
Brazil. (Translated from Portuguese: ‘National Manual for
Laboratory Surveillance of Tuberculosis and Other Myco-
(12 of 13) e2100066
© 2021 Wiley-VHCA AG, Zurich, Switzerland